Key result
Aggressive chemotherapy with the CODOX-M/IVAC regimen reduced the size of multiple cardiac masses and stabilized the clinical condition of a 37-year-old male with secondary cardiac lymphoma.
Population
37-year-old male with secondary cardiac lymphoma presenting with multiple intracardiac masses, cough…
Design
Case_report
Follow-up
1 week after starting chemotherapy
Authors
Loading...
May support chemotherapy response in secondary cardiac lymphoma; hypothesis-generating and should not yet change practice.
Case Report (n=1)
Multimodality imaging is essential for the diagnosis, staging, and monitoring of secondary cardiac lymphoma, which can respond rapidly to aggressive chemotherapy.
Indrabhinduwat et al. (2018) conducted a case report in Secondary cardiac lymphoma (n=1). Chemotherapy (CODOX-M/IVAC regimen) was evaluated on Tumor size and clinical response. Aggressive chemotherapy with the CODOX-M/IVAC regimen reduced the size of multiple cardiac masses and stabilized the clinical condition of a 37-year-old male with secondary cardiac lymphoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: